Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media

被引:109
作者
Bartolozzi, Carlo
Crocetti, Laura
Lencioni, Riccardo
Cioni, Dania
Della Pina, Clotilde
Campani, Daniela
机构
[1] Univ Pisa, Dept Oncol Transplant & Advanced Technol Med, Div Diagnost & Intervent Radiol, I-16125 Pisa, Italy
[2] Univ Pisa, Dept Oncol Transplant & Advanced Technol Med, Div Pathol, Pisa, Italy
关键词
hepatocellular carcinoma; carcinogenesis; magnetic resonance imaging; contrast media;
D O I
10.1007/s00330-007-0602-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The development and progression of a hepatocellular carcinoma (HCC) in a chronically diseased liver, i.e., the carcinogenesis, comprise a multistep and long-term process. Morphologically, this process is associated with the presence of distinct nodular lesions in the liver that are called 'preneoplastic lesions.' These preneoplastic lesions are associated with and can precede the growth and progression of well-differentiated HCCs . The characterization of nodular lesions and demonstration of the multistep development of HCC in the cirrhotic liver by imaging modalities represent a challenging issue. The arterial hypervascular supply, depicted by different dynamic studies, represents a fundamental radiological criterion for the diagnosis of HCC in cirrhosis. Magnetic resonance (MR) imaging performed with tissue-specific contrast media can help to investigate the "grey area" of carcinogenesis, in which significant histological changes are already present without any imaging evidence of neoangiogenesis. The purpose of this review is to provide information on the properties of tissue-specific MR contrast agents and on their usefulness in the demonstration of the pathologic changes that take place at the level of the biliary and reticuloendothelial systems during the carcinogenetic process in liver cirrhosis.
引用
收藏
页码:2519 / 2530
页数:12
相关论文
共 80 条
[1]  
ANTHONY PP, 1989, RECENT ADV HISTOPATH, P185
[2]   MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis [J].
Bartolozzi, C ;
Donati, F ;
Cioni, D ;
Crocetti, L ;
Lencioni, R .
EUROPEAN RADIOLOGY, 2000, 10 (11) :1697-1702
[3]   Hepatocellular carcinoma in cirrhotic livers: Double-contrast thin-section MR imaging with pathologic correlation of explanted tissue [J].
Bhartia, B ;
Ward, J ;
Guthrie, JA ;
Robinson, PJ .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 180 (03) :577-584
[4]   Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development [J].
Borzio, M ;
Fargion, S ;
Borzio, F ;
Fracanzani, AL ;
Croce, AM ;
Stroffolini, T ;
Oldani, S ;
Cotichini, R ;
Roncalli, M .
JOURNAL OF HEPATOLOGY, 2003, 39 (02) :208-214
[5]   Preneoplastic cellular changes in liver [J].
Borzio, M ;
Roncalli, M ;
Treré, D ;
Derenzini, M .
HEPATOLOGY, 1998, 28 (05) :1435-1436
[6]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[7]   LIVER-TUMORS IN CIRRHOSIS - EXPERIMENTAL-STUDY WITH SPIO-ENHANCED MR IMAGING [J].
CLEMENT, O ;
FRIJA, G ;
CHAMBON, C ;
SCHOUMANCLAYES, E ;
MOSNIER, JF ;
POUPON, MF ;
BALKAU, B .
RADIOLOGY, 1991, 180 (01) :31-36
[8]   Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging [J].
Coffin, CM ;
Diche, T ;
Mahfouz, AE ;
Alexandre, M ;
Caseiro-Alves, F ;
Rahmouni, A ;
Vasile, N ;
Mathieu, D .
EUROPEAN RADIOLOGY, 1999, 9 (03) :444-449
[9]  
DEHAEN C, 1996, ACAD RADIOL, V3, pS450
[10]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO